Skip to main content
The BMJ logoLink to The BMJ
letter
. 1993 Jan 9;306(6870):147. doi: 10.1136/bmj.306.6870.147-a

"Economic relevance" in pharmacoeconomic studies.

J A Sacristán, J Hernández, J Soto
PMCID: PMC1676654  PMID: 8435636

Full text

PDF

Page 147

147

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Detsky A. S., Naglie I. G. A clinician's guide to cost-effectiveness analysis. Ann Intern Med. 1990 Jul 15;113(2):147–154. doi: 10.7326/0003-4819-113-2-147. [DOI] [PubMed] [Google Scholar]
  2. Doubilet P., Weinstein M. C., McNeil B. J. Use and misuse of the term "cost effective" in medicine. N Engl J Med. 1986 Jan 23;314(4):253–256. doi: 10.1056/NEJM198601233140421. [DOI] [PubMed] [Google Scholar]
  3. Eisenberg J. M. Clinical economics. A guide to the economic analysis of clinical practices. JAMA. 1989 Nov 24;262(20):2879–2886. doi: 10.1001/jama.262.20.2879. [DOI] [PubMed] [Google Scholar]
  4. Udvarhelyi I. S., Colditz G. A., Rai A., Epstein A. M. Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly? Ann Intern Med. 1992 Feb 1;116(3):238–244. doi: 10.7326/0003-4819-116-3-238. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES